Drugs / ChAdOx1 Chik
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04440774 | Oct 2020 → Feb 2022 | Zika virus infectious disease, chikungunya | University of Oxford | Completed | No outcome recorded |
| Phase 1 | NCT03590392 | Jul 2018 → Sep 2019 | chikungunya | University of Oxford | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAdOx1 Chik | “A single dose of 5x10\^9 vp ChAdOx1 Chik” NCT04440774 ↗ |
| Modality | Vaccine | “candidate vaccine ChAdOx1 Chik” NCT03590392 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT03590392 ↗ |